Richard Geary
Vermogen: 5 M $ op 31-05-2026
Vermogen: 5 M $ op 31-05-2026
Richard S.
Geary is currently Director at Oligonucleotide Therapeutics Society, Inc. Formerly, Dr. Geary was Vice President-Preclinical Development at Ionis Pharmaceuticals, Inc. from 2003 to 2008 and worked at Southwest Research Institute as Senior Research Scientist.
Education includes undergraduate studies at Texas A&M University and a doctorate from The University of Texas at Austin conferred in 1987.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 59.657 ( 0,04% ) | 5 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2026 |
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau